Metastatic uveal melanoma showing durable response to anti-CTLA-4 and anti-PD-1 combination therapy after experiencing progression on anti-PD-1 therapy alone

por Afzal, Muhammad Zubair, Mabaera, Rodwell, Shirai, Keisuke
Publicado 2018

Does denosumab offer survival benefits? —Our experience with denosumab in metastatic non-small cell lung cancer patients treated with immune-checkpoint inhibitors

por Cao, Yenong, Afzal, Muhammad Zubair, Shirai, Keisuke
Publicado 2021

Efficacy of metformin in combination with immune checkpoint inhibitors (anti-PD-1/anti-CTLA-4) in metastatic malignant melanoma

por Afzal, Muhammad Zubair, Mercado, Rima R., Shirai, Keisuke
Publicado 2018

Overexpression of MRPL19 in predicting poor prognosis and promoting the development of lung adenocarcinoma

por Wei, Dong, Sun, Daqiang, Sirera, Rafael, Afzal, Muhammad Zubair, Leong, Tracy L., Li, Xin, Wang, Yuhang
Publicado 2023

Spontaneous Regression of Refractory Diffuse Large B-Cell Lymphoma with Improvement in Immune Status with ART in a Patient with HIV: A Case Report and Literature Review

por K.C., Birendra, Afzal, Muhammad Zubair, Wentland, Katherine A., Hashmi, Hamza, Singh, Sudhir, Ivan, Elena, Lakhani, Nehal
Publicado 2015

Neoadjuvant programmed cell death protein 1 inhibitors combined with chemotherapy in resectable non-small cell lung cancer: an open-label, multicenter, single-arm study

por Duan, Hongtao, Wang, Tianhu, Luo, Zhilin, Tong, Liping, Dong, Xiaoping, Zhang, Yong, Afzal, Muhammad Zubair, Correale, Pierpaolo, Liu, Honggang, Jiang, Tao, Yan, Xiaolong
Publicado 2021